Physician profile
Judith E Bowers
NPI 1518941418
$13,236.13
in general payments reported to CMS, 2019-2025
29 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $9,068 · 2021: $3,136 · 2022: $183 · 2023: $79.22 · 2024: $258 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $538.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,063.17 | 2019-2021 | |
| Aspira Women'S Health INC | $164.26 | 2021-2025 | Ova1 |
| Medtronic, INC. | $101.49 | 2022 | |
| Insulet Corporation | $99.62 | 2019 | |
| Abbvie INC. | $90.86 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $78.66 | 2024-2025 | Gemtesa, Myfembree |
| Shield Therapeutics INC | $68.57 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $60.65 | 2023-2025 | Slynd |
| Pfizer INC. | $49.75 | 2021-2024 | |
| Astellas Pharma US INC | $49.12 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $38.90 | 2022-2024 | |
| Axonics, INC. | $38.37 | 2024 | Axonics, Bulkamid |
| Sanofi-Aventis U.S. LLC | $33.12 | 2025 | |
| Amgen INC. | $31.15 | 2023-2024 | Evenity, Prolia |
| Biogen, INC. | $29.09 | 2025 | Zurzuvae |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $27.77 | 2022 | |
| Therapeuticsmd, INC. | $24.54 | 2019-2022 | |
| Lupin INC. | $22.65 | 2019-2020 | |
| Coopersurgical, INC. | $21.32 | 2020 | |
| Conmed Corporation | $19.82 | 2023 | Airseal |
| Gilead Sciences, INC. | $17.34 | 2019 | |
| Kedrion Biopharma INC. | $17.18 | 2019 | |
| Minerva Surgical, INC | $16.20 | 2019 | |
| Merck Sharp & Dohme LLC | $15.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.03 | 2019 | |
| Coloplast Corp | $11.70 | 2019 | |
| Avion Pharmaceuticals | $11.47 | 2019 | |
| Allergan, INC. | $10.80 | 2019 | |
| Meditrina | $10.31 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Bowers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.